LTC Properties Inc vs 22nd Century Group Inc — how do they compare? LTC Properties Inc trades at $41.74 (market cap $2.15B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: LTC Properties Inc is far larger — about 1443× 22nd Century Group Inc's market cap, and LTC Properties Inc pays a 5.44% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| LTC | XXII | |
|---|---|---|
Market Cap | $2.15B | $1.49M |
Sector | Real Estate | Technology |
52-Week High | $41.92 | $1.07K |
52-Week Low | $33.98 | $3.90 |
Enterprise Value | $2.99B | -$6.74M |
Dividend Yield | 5.44% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $4.32, down 0.23% with bearish technical signals. The company shows negative profitability with -65.76% net income margin and -130.19% ROE, though valuation ratios appear low with P/S of 0.03. Recent corporate actions include a 20:1 reverse stock split in June 2026. The company is expanding VLN product distribution in key markets including California and New York, supported by positive FDA regulatory developments.
While analyst consensus is 75% buy-rated, fundamental challenges persist with consistent revenue declines and negative cash flow from operations. Investment opportunity lies in successful VLN brand expansion and regulatory approvals, but risks include ongoing losses, competitive tobacco market pressures, and execution uncertainty in scaling reduced-nicotine products.
Trailing returns across standard periods
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →